Becotatug Vedotin Combined With Pucotenlimab ± Radiotherapy as First-Line Treatment for Driver-Gene-Negative, EGFR-Expression-Positive Advanced Non-Small Cell Lung Cancer
Clinical trial NCT07627321 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07627321
- Sponsor
- Anhui Provincial Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-15
- Primary completion
- 2028-07-16
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.